Skip to main content

Celldex Therapeutics, Inc.

CLDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0000744218

No open-market purchases or sales by Celldex Therapeutics, Inc. insiders were filed in the last 90 days; 253 institutions reported holding it in 13F filings for Q2 2026, worth $3.16B in total; no superinvestor holds it.

13F holders, Q2 2021

Institutional positions in Celldex Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
132
+17 vs. Q1 2021
Shares held
35.3M
+769.6K (+2.2%) vs. Q1 2021
Total value
$1.19B
+$484.4M (+68.3%) vs. Q1 2021
New holders
40
33 more added
Sold out
23
36 more reduced

Compare with Q1 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CLDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2021: 132 institutions
Q1 2021: 115 institutionsQ2 2021: 132 institutionsQ3 2021: 161 institutionsQ4 2021: 181 institutionsQ1 2022: 169 institutionsQ2 2022: 158 institutionsQ3 2022: 160 institutionsQ4 2022: 168 institutionsQ1 2023: 161 institutionsQ2 2023: 150 institutionsQ3 2023: 144 institutionsQ4 2023: 164 institutionsQ1 2024: 197 institutionsQ2 2024: 183 institutionsQ3 2024: 176 institutionsQ4 2024: 174 institutionsQ1 2025: 171 institutionsQ2 2025: 182 institutionsQ3 2025: 184 institutionsQ4 2025: 187 institutionsQ1 2026: 229 institutionsQ2 2026: 253 institutions
Value heldQ2 2021: $1.19B
Q1 2021: $709.5MQ2 2021: $1.19BQ3 2021: $2.33BQ4 2021: $1.79BQ1 2022: $1.69BQ2 2022: $1.30BQ3 2022: $1.39BQ4 2022: $2.17BQ1 2023: $1.78BQ2 2023: $1.70BQ3 2023: $1.39BQ4 2023: $2.42BQ1 2024: $2.91BQ2 2024: $2.58BQ3 2024: $2.44BQ4 2024: $1.86BQ1 2025: $1.34BQ2 2025: $1.48BQ3 2025: $1.83BQ4 2025: $1.99BQ1 2026: $2.31BQ2 2026: $3.16B
Institutions holding CLDX and their total value by quarter
QuarterHoldersValue
Q2 2026253$3.16B
Q1 2026229$2.31B
Q4 2025187$1.99B
Q3 2025184$1.83B
Q2 2025182$1.48B
Q1 2025171$1.34B
Q4 2024174$1.86B
Q3 2024176$2.44B
Q2 2024183$2.58B
Q1 2024197$2.91B
Q4 2023164$2.42B
Q3 2023144$1.39B
Q2 2023150$1.70B
Q1 2023161$1.78B
Q4 2022168$2.17B
Q3 2022160$1.39B
Q2 2022158$1.30B
Q1 2022169$1.69B
Q4 2021181$1.79B
Q3 2021161$2.33B
Q2 2021132$1.19B
Q1 2021115$709.5M

Institutions, Q2 2021

Shares, value and share of portfolio for each institution holding Celldex Therapeutics, Inc.; share changes are against Q1 2021.

Institutions holding CLDX in Q2 2021
InstitutionSharesValue% of portfolioChange in sharesAction
AXA S.A.228,951$7.66M0.02%−68,832−23.1%Reduced
Ghost Tree Capital, LLC285,000$9.53M2.98%+35,000+14.0%Added
Commodore Capital LP323,437$10.8M3.77%−46,514−12.6%Reduced
Goldman Sachs Group Inc338,055$11.3M0.00%−130,826−27.9%Reduced
TSP Capital Management Group, LLC–$11.4M3.74%––
Dimensional Fund Advisors LP359,424$12.0M0.00%+56,072+18.5%Added
Renaissance Technologies LLC364,027$12.2M0.02%−177,400−32.8%Reduced
Ikarian Capital, LLC365,544$12.2M2.18%−230,746−38.7%Reduced
FMR LLC366,295$12.2M0.00%+28,395+8.4%Added
Citadel Advisors LLC371,171$12.4M0.01%−604,845−62.0%Reduced
Price T Rowe Associates Inc389,048$13.0M0.00%+56,818+17.1%Added
Candriam Luxembourg S.C.A.399,685$13.4M0.09%+55,546+16.1%Added
Northern Trust Corp412,263$13.8M0.00%+305,057+284.6%Added
Invesco Ltd.430,407$14.4M0.00%+169,912+65.2%Added
Cresset Asset Management, LLC457,666$15.3M0.22%00.0%Unchanged
Polar Capital Holdings Plc500,000$16.7M0.09%00.0%Unchanged
Octagon Capital Advisors LP561,398$18.8M3.89%00.0%Unchanged
Driehaus Capital Management LLC585,311$19.6M0.26%+236,471+67.8%Added
Geode Capital Management, LLC672,948$22.5M0.00%+320,251+90.8%Added
Perceptive Advisors LLC742,699$24.8M0.32%+742,699New
Vivo Capital, LLC968,906$32.4M1.40%−322,969−25.0%Reduced
Opaleye Management Inc.985,000$32.9M5.47%00.0%Unchanged
Acuta Capital Partners, LLC987,406$33.0M14.14%−30,118−3.0%Reduced
VR Adviser, LLC1,240,610$41.5M5.03%00.0%Unchanged
Adage Capital Partners GP, L.L.C.1,818,478$60.8M0.12%−81,522−4.3%Reduced
Wellington Management Group LLP1,962,999$65.6M0.01%+74,263+3.9%Added
Vanguard Group Inc1,970,406$65.9M0.00%+172,079+9.6%Added
State Street Corp2,094,218$70.0M0.00%+217,241+11.6%Added
Eventide Asset Management, LLC2,108,908$70.5M0.95%+46,475+2.3%Added
BlackRock Inc.2,700,650$90.3M0.00%+1,732,777+179.0%Added
Redmile Group, LLC3,012,081$100.7M1.49%−375,707−11.1%Reduced
RTW Investments, LP3,908,947$130.7M1.97%00.0%Unchanged
Millennium Management LLC0$00.00%−505,163−100.0%Sold out
Sphera Funds Management Ltd.0$00.00%−220,320−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−135,552−100.0%Sold out
Verition Fund Management LLC0$00.00%−133,064−100.0%Sold out
HRT Financial LP0$00.00%−110,306−100.0%Sold out
California Public Employees Retirement System0$00.00%−78,426−100.0%Sold out
Alps Advisors Inc0$00.00%−71,581−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−64,913−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−46,100−100.0%Sold out
Squarepoint Ops LLC0$00.00%−44,995−100.0%Sold out
Maven Securities LTD0$00.00%−28,492−100.0%Sold out
Jefferies Group LLC0$00.00%−25,637−100.0%Sold out
LMR Partners LLP0$00.00%−25,352−100.0%Sold out
Marshall Wace North America L.P.0$00.00%−24,261−100.0%Sold out
Marshall Wace, LLP0$00.00%−20,580−100.0%Sold out
Virginia Retirement Systems Et Al0$00.00%−14,000−100.0%Sold out
Pinz Capital Management, LP0$00.00%−5,000−100.0%Sold out
Pacer Advisors, Inc.0$00.00%−2,828−100.0%Sold out
Lindbrook Capital, LLC0$00.00%−1,000−100.0%Sold out
Jacobi Capital Management LLC0$00.00%−400−100.0%Sold out
MPS Loria Financial Planners, LLC0$00.00%−133−100.0%Sold out
Bank of Montreal0$00.00%−60−100.0%Sold out
Sowell Financial Services LLC0$00.00%−13−100.0%Sold out